Natures Sunshine Products INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D/A: Fosun Pharma USA Divests Significant Stake in Nature's Sunshine Products, Ceasing Majority Ownership
Fosun Pharma USA Inc. has completed the sale of over 2.8 million shares of Nature's Sunshine Products Inc. common stock, reducing its beneficial ownership to below 5%.
NASDAQ
SCHEDULE 13D/A: Fosun Pharma Transfers Significant Stake in Nature's Sunshine Products to U.S. Subsidiary
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has transferred 2,854,607 shares of Nature's Sunshine Products, Inc. common stock to its wholly-owned U.S. subsidiary, Fosun Pharma USA Inc., as disclosed in an amended Schedule 13D filing.